Endocrinology

The FDA has been granting priority review to more pipeline drugs without skimping on application standards. What makes up a viable novel therapy application, specialty by specialty?

A new statement from the US Preventive Services Task Force emphasizes the need for behavior-based interventions to help adults with obesity lose weight and maintain lower weight.

Even though my practice partner and I are perfectly fine together and have been for years, I wonder now and then if we should hire. Still wondering.

Can weight loss alone be the key to the reversal of type 2 diabetes? A new study sheds some light. 

Growth hormone replacement therapy in adults is effective, but not risk-free. Find out what you know about the good vs not-so-good.

The novel long-acting recombinant human growth hormone may lower number of growth hormone treatments from daily to 2 times per month.

Male thyroid cancer survivors are at a 50% increased risk for developing heart disease vs women, according to one of the first studies of its kind. 

Deaths due to drug overdoses and suicides have contributed to decreasing US life expectancy, but other factors indicate that there is a deeper root cause driving these trends.

How will the newly proposed Centers for Medicare & Medicaid Services fee schedule impact your practice? One physician explains. 

The principles included new and updated evidence over recent years in the field of diabetes self-management, education, and support, as well as shared decision-making skills and individualized care for patients.

15 years ago, the Los Angeles-based educator and public health professional introduced Canary Health with his son. Here’s how the father-son team improved diabetes management online.

A class of drugs indicated for use with diet and exercise in patients with type 2 diabetes, has been linked to necrotizing fasciitis of perineum (Fournier’s gangrene).

How the conflicting results of the ASCEND trial are actually much more determinant than they appear, and critical in the scope of treating comorbidities in patients with diabetes.

Highlights include obstructive sleep apnea as a factor for T2DM; a test that distinguishes between T1DM and T2DM; and missed opportunities in diabetes prevention.

As more physicians are caring for transgender patients, many are finding they are unprepared and they lack the training, skills, and resources to do so, according to the authors of a recent review article.

In a 15,000-plus patient analysis that spanned more than 7 years, aspirin reduced vascular risks in patients—but also increased their rate of major bleeding events.

Results from a 12-month extension study show that elagolix taken with hormone therapy reduced menstrual blood loss in 87.9% of women with uterine fibroids.

A new study found that left ventricular diastolic function is linked to poor glycemic control and A1c in T2DM patients. 

Patients with T2DM and proven cardiovascular disease have elevated markers of inflammation and endothelial stress, according to a new study.

The celebrity chef-turned-producer wants to champion healthcare access, both on the screen and in person. Where does he start?

Pituitary dysfunction secondary to traumatic brain injury is receiving increased scrutiny and GHD is the most common isolated deficit. Which test to use?

The results of a new study point to age-related macular degeneration, diabetic retinopathy, and glaucoma as potential early warning signs that an individual is at risk for developing Alzheimer disease or dementia.

A new orally administered diagnostic test for adult human growth hormone deficiency also may prove more convenient for patients and clinicians.

Are basal insulin analogues all that different from each other in their glucose-lowering effects? According to a new study, not really. 

The recall comes after the FDA issued an Import Alert concerning Sichuan Friendly Pharmaceutical Co., Ltd., which was found to have substandard manufacturing practices.

From BMD T-scores in adults with GHD to how GH supplementation affects cardiac function--test your knowledge of the details.

Highlights include how cost-effective insulin reduces hospital visits; prevalence of restrictive lung disease in T2DM patients; and the wonders of self-monitoring for cost of care.

How do low- and high-normal levels of IGF-1 impact cognitive function and wellbeing during growth hormone replacement?  Answers from a new study.

Results of a new study highlight the importance of intensive treatment of all comorbidities associated with adult growth hormone deficiency.

The optimal duration of dual antiplatelet therapy remains unclear, despite being proven efficacious for roughly 2 decades.